• No results found

Curcumin elevates sirtuin level but does not postpone in vitro senescence of human cells building the vasculature

N/A
N/A
Protected

Academic year: 2020

Share "Curcumin elevates sirtuin level but does not postpone in vitro senescence of human cells building the vasculature"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1: The impact of curcumin on replicative senescence of VSMC. A. cPD of VSMC treated with different concentrations of curcumin (0.1 or 1 µM)
Figure 2: The impact of curcumin on replicative senescence of EC. A. cPD of EC treated with curcumin (0.1 µM)
Figure 3: The impact of curcumin on stress induced premature senescence of VSMC. A. Analysis of DNA damage in VSMC upon treatment with curcumin (0.1 or 1 µM) together with doxorubicin (10, 25 or 50 nM) expressed as a number of 53BP1 foci, after 3 and 7 day
Figure 4: The impact of single application of low doses of curcumin on some parameters characteristic for cellular senescence
+3

References

Related documents

Key beliefs underlying public feeding of free-roaming cats in Malaysia and management suggestions.. Human Dimensions of Wildlife,

This findings is in line with what was found by Mary Ann Seday (2007) in which the proportion of youth reporting “never having sex” increased from 88 to 92 per cent, after

glycan samples.. HPLC separation of a complex mixture seldom resolves peaks and MS scans contain many species at any given time. B) A single precursor MS scan with several peptides,

In this paper, however, we show that Islam and Biswas’s scheme cannot achieve the claimed security goals and report its flaws: (1) It is vulnerable to offline password guessing

We compared the response of ROS to LFMC in shrubland fire experiments obtained when including the different sources of uncertainties and biases mentioned above with other

In highlighting bidding success as becoming more central to the competitiveness of destinations, Getz (2004) laments that most research attention has been paid to

Secondary outcomes include culture-proven bacteraemia at 12 and 24 months; primary, secondary and functional patency rates at 3, 6, 12 and 24 months; stenosis, thrombosis

We emphasize once again the need for a broad structure for active, systematic, intensive collection of methodically assessed data from observational prospective and other